PMID- 18303411 OWN - NLM STAT- MEDLINE DCOM- 20080409 LR - 20191210 IS - 1052-9551 (Print) IS - 1052-9551 (Linking) VI - 17 IP - 1 DP - 2008 Mar TI - Detection of FOXO1 (FKHR) gene break-apart by fluorescence in situ hybridization in formalin-fixed, paraffin-embedded alveolar rhabdomyosarcomas and its clinicopathologic correlation. PG - 14-20 LID - 10.1097/PDM.0b013e3181255e62 [doi] AB - Chromosomal translocations of t(2;13)(q35;q14) and t(1;13)(p36;q14), resulting in PAX3-FOXO1 (FKHR) and PAX7-FOXO1 (FKHR) gene fusions, have been found to be specific molecular markers for alveolar rhabdomyosarcomas (ARMS) and can be identified in approximately 80% cases. As the prognosis of ARMS is worse than that of embryonal rhabdomyosarcomas (ERMS), it is important to accurately distinguish between these 2 subtypes. This distinction may be difficult on the basis of morphology alone. To detect the genetic alterations, reverse transcriptase polymerase chain reaction (RT-PCR) or dual-color dual-fusion fluorescence in situ hybridization (FISH) have been used in most studies so far. In this study, we used FOXO1 (FKHR) gene break-apart FISH probe, which can detect both of the translocations involving the FOXO1 gene, and tested 20 cases of rhabdomyosarcoma (RMS) including 6 cases of ARMS, 8 ERMS, 1 pleomorphic type, 5 not otherwise specified (RMS-NOS), and 10 non-RMS sarcomas. A home-brew RT-PCR that could detect both PAX3-FOXO1 and PAX7-FOXO1 was also performed. Four pathologists independently reviewed all RMS and a consensus diagnosis was also reached in discrepant cases. Histologic and molecular findings were correlated with clinical outcomes with an average of a 49-month follow-up. FOXO1 break-apart by FISH was positive in 4 of 6 (66%) ARMS and 2 of 5 (40%) RMS-NOS cases. All other cases, including all ERMS, were negative. RT-PCR assay confirmed all FISH results. While 2 of 6 (33%) RMS patients with a FOXO1 break-apart died of the disease, there were no deaths among the patients with negative result. The FOXO1 gene break-apart FISH probe is a simple and accurate tool to detect the translocations associated with ARMS. As characteristic genetic alterations of ARMS can be identified in 40% of RMS-NOS cases in our study, the FISH assay would provide an additional useful tool in the diagnosis and prognosis of ARMS, and an alternative to RT-PCR. FAU - Mehra, Shveta AU - Mehra S AD - Department of Pathology, SUNY Upstate Medical University, Syracuse, NY, USA. FAU - de la Roza, Gustavo AU - de la Roza G FAU - Tull, Jamie AU - Tull J FAU - Shrimpton, Antony AU - Shrimpton A FAU - Valente, Alfredo AU - Valente A FAU - Zhang, Shengle AU - Zhang S LA - eng PT - Evaluation Study PT - Journal Article PL - United States TA - Diagn Mol Pathol JT - Diagnostic molecular pathology : the American journal of surgical pathology, part B JID - 9204924 RN - 0 (FOXO1 protein, human) RN - 0 (Forkhead Box Protein O1) RN - 0 (Forkhead Transcription Factors) RN - 0 (Oncogene Proteins, Fusion) RN - 1HG84L3525 (Formaldehyde) SB - IM MH - Adolescent MH - Adult MH - Base Sequence MH - Child MH - Child, Preschool MH - *Chromosome Breakage MH - Chromosomes, Human, Pair 1 MH - Chromosomes, Human, Pair 13 MH - Chromosomes, Human, Pair 2 MH - Female MH - Forkhead Box Protein O1 MH - Forkhead Transcription Factors/*genetics MH - Formaldehyde/*pharmacology MH - Humans MH - *In Situ Hybridization, Fluorescence MH - Infant MH - Male MH - Middle Aged MH - Molecular Sequence Data MH - Muscle Neoplasms/*diagnosis/*genetics MH - Oncogene Proteins, Fusion/genetics MH - *Paraffin Embedding MH - Prognosis MH - Rhabdomyosarcoma, Alveolar/*diagnosis/*genetics MH - Translocation, Genetic MH - Tumor Cells, Cultured EDAT- 2008/02/28 09:00 MHDA- 2008/04/10 09:00 CRDT- 2008/02/28 09:00 PHST- 2008/02/28 09:00 [pubmed] PHST- 2008/04/10 09:00 [medline] PHST- 2008/02/28 09:00 [entrez] AID - 10.1097/PDM.0b013e3181255e62 [doi] PST - ppublish SO - Diagn Mol Pathol. 2008 Mar;17(1):14-20. doi: 10.1097/PDM.0b013e3181255e62.